Analytical Data
-
基因名
EGR4
- Application
-
别名
NGFI-C; PAT133
-
种属
Mouse
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9WUF2
-
表达区间
Ala231~Ser474
-
分子量
33kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EGR4 (Early Growth Response Protein 4) is a member of the EGR family of transcription factors, playing a pivotal role in various physiological and pathological processes, including neuronal development, synaptic plasticity, and tumorigenesis. The expression of EGR4 is tightly regulated, with its activity influenced by numerous stimuli such as growth factors and neural activity. Disruptions in EGR4 expression or function have been implicated in several neurodegenerative diseases and cancers, making it a significant target for therapeutic intervention. Researchers have increasingly focused on the recombinant expression of EGR4 to understand its biological functions more deeply and explore its potential as a biomarker or therapeutic target. Advances in molecular cloning and protein expression technologies have facilitated the production of EGR4 recombinant proteins, allowing for detailed studies on its structure, interaction with DNA, and modulation of downstream gene expression. Understanding the function of EGR4 at a molecular level is essential for elucidating its role in health and disease, as well as for the development of novel treatment strategies that could leverage its activities in various cellular contexts. The study of EGR4 recombinant proteins is thus a crucial step towards unraveling its complex biology and therapeutic potential.
